Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Sharda Cropchem Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue Rs 1,052 Cr (+13%), EBITDA Rs 164 Cr (+18%), margin 15.6%, PAT Rs 92 Cr (+23%). H1 PAT down 17%.

Highlights
Revenue growthQ2 +13%, H1 +11% consolidated revenue
MarginsQ2 EBITDA margin 15.6% (+70 bps); H1 16.1% (+140 bps)
Demand visibilityNAFTA, LATAM agro strong; Europe agro declining

Growth

Q2 agro Rs 840 Cr (+5%), non-agro Rs 212 Cr (+68%). H1 EBITDA +22%, margin 16.1% (+140 bps).

Outlook

No numeric guidance. H1 capex Rs 419 Cr; working capital days cut 98 to 70; forward integration into sales force.

Risks

Europe agro down 7% in Q2, 9% in H1. H1 PAT margin fell to 8.5% from 11.3%; receivables Rs 1,461 Cr.

Last quarter's promises, checked

Partly delivered

  • Guided FY27 revenue +10–15% → H1 +11%, Q2 +13% (= PARTIAL, FY open)
  • Guided FY27 capex ~Rs 500 Cr (480–550) → H1 Rs 419 Cr (= PARTIAL, H2 open)

Missed

  • Guided EBITDA margin 18–20% → H1 16.1% (Q2 15.6%) (= MISS)
  • Guided Europe volumes to recover, 'next 3 quarters better than Q1' → Europe agro Q2 -7%, H1 -9% (= MISS)
Source

Investor Presentation filed with BSE, NSE: SHARDACROP. Summary written with AI assistance from the document.

Read the document ↗

Sharda Cropchem Ltd: key numbers

Share price
₹686.20
Market cap
₹6,191 Cr
Revenue (annual)
₹5,268 Cr
Net profit (annual)
₹680.9 Cr
P/E (TTM)
9.9×Sector 34.1×
Promoter holding
74.82%+0.00% QoQ
FII holding
3.27%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sharda Cropchem Ltd

All →